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Abstract: 
Objective: It has been noted that the presence of Helicobacter pylori (H. pylori) 
in the oral cavity may affect the outcome of eradication therapy. This condition is 
associated with the recurrence of gastric infection. The optimum secretion of sali-
va promotes oral health consequently influencing H. pylori eradication. The pur-
pose of this study was to investigate the relation between salivary secretion and 
the efficacy of H. pylori eradication from the stomach.  
Materials and Methods: Forty five patients with gastric H. pylori infection were 
enrolled in this study. Diagnosis of H. pylori infection was confirmed by endos-
copy, biopsy, urease test and histological examination. Salivary secretion of all 
participants was determined under standard condition before the beginning of an-
tibacterial treatment. Then the patients were treated with a 14-day course anti-H. 
pylori regimen consisting of amoxicillin, omeprazole, metronidazole and bismuth. 
The efficacy of eradication therapy was evaluated 4 weeks after the end of the 
treatment course. Mann-Whitney U test was used to analyze the variables. 
Results: The median of salivary secretion among successful and unsuccessful H. 
pylori  eradication  groups  was  0.48  ml/min  and  0.24  ml/min,  respectively 
(p=0.005). 
Conclusion: Although the type of drug regimens is challenging, the efficacy of 
H. pylori eradication from the stomach might be reduced by lower salivary secre-
tion. 
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INTRODUCTION 
Helicobacter pylori (H. pylori) is a spiral gram 
negative  bacterium  that  colonizes  the  human 
gastrointestinal tract and is responsible for ga-
stritis and peptic ulcers as well as a risk factor 
for  gastric  cancer  [1].  The  fecal-oral  tract  is 
believed to be a common route of transmission 
of H. pylori so low levels of sanitation and so-
cioeconomic status are associated with an in-
creased prevalence of H. pylori infection [2]. 
Several studies have demonstrated that H. py-
lori presence in the oral cavity has a clear as-
sociation with gastro esophageal infection [3-
5];  therefore,  failure  to  eliminate  H.  pylori 
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from the mouth could lead to gastrointestinal 
reinfection  [4-6].  The  recent  PCR  analysis 
showed H. pylori DNA in dental plaques and 
saliva,  suggesting  that  the  oral  environment 
may be one of the many potential pathways for 
transmission  [4,  7-9].  Numerous  factors  may 
influence  the  effectiveness  of  anti-  H.  pylori 
therapy.  Since  oral  cavity  could  serve  as  a 
sanctuary for H. pylori, survival of the bacteria 
in the mouth despite their eradication from the 
stomach may promote early reinfection of the 
stomach  reducing  the  efficacy  of  eradication 
therapy [10,11]. It is well understood that poor 
salivary secretion may contribute to the depo-
sition of dental plaque because of the loss of 
natural  cleansing  of  the  oral  cavity.  On  the 
other hand, low salivary secretion apply favor-
able  environment  for  the  growth  of  bacteria 
including H. pylori. The purpose of the present 
study was to evaluate the relationship between 
salivary flow rate and the efficacy of a certain 
H. pylori eradication regimen among patients 
suffering from peptic ulcer.  
 
MATERIALS AND METHODS 
A total of forty five patients with H. pylori in-
fected peptic ulcer from the Gastroenterology 
department  of  Ekbatan  Hospital,  Hamadan 
University of Medical Sciences were recruited 
















Inclusion criteria were positive gastric H. py-
lori infection, at least 7 days without drug con-
sumption and no underlying systemic diseases. 
Pregnant and breast feeding women, smokers 
and  alcohol  abusers  and  those  with  salivary 
gland disorders were excluded from the study. 
All  participants  signed  a  standard  informed 
consent form approved by the local institution-
al ethical committee.  
Endoscopic examination was done by one ex-
perienced endoscopist for all patients. Gastric 
mucosa specimens were taken from pre-pylor 
and body regions for urease test and histologi-
cal examination [6].  
Then the patients were included in the study if 
the findings of both H. pylori tests were posi-
tive.  
Before the beginning of H. pylori eradication 
regimen,  whole  unstimulated  saliva  samples 
were collected on the next day after endoscopy 
by the standard method [12]. All sample col-
lections  were  done  between  8:00  AM  and 
10:00 AM to prevent diurnal variations. Sub-
jects  were  instructed  not  to  drink  or  eat  and 
perform  oral  hygiene  procedures  for  90  mi-
nutes before the collection.  
The patients were asked to expectorate into a 
standard scaled test tube every one minute for 
a total of 5 minutes. Finally, the results were 


















Characteristic                                               Successful Eradication                      Unsuccessful Eradication             P value 
          (n=30)                                                 (n=15) 
              (years) (median)                                    35                                                     38      
Age                       





Women, n (%)                                                11 (36.7)                                            6 (40) 
                                                                                                                                                                           0.82 
Men, n (%)                                                      19 (63.3)                                            9 (60) 
 
Table 1. Characteristics of Patients Regarding the Efficacy of H. Pylori Eradication 
*Mann-Whitney U test 
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After endoscopy and saliva collection, the era-
dication  regimen  was  started  as  below:  1) 
Amoxicillin  2×1000  mg  2)  Metronidazole 
2×500  mg  3)  Omeprazole  2×20  mg  and  4) 
Bismuth  2×240  mg.  These  drugs  were  taken 
twice daily for a period of 2 weeks. The effi-
cacy of H. pylori eradication from the stomach 
was evaluated by C-13 urea breath test (UBT) 
four weeks after the end of the treatment regi-
men [13]. The eradication efficacy was judged 
successful if the finding of UBT for H. pylori 
was  negative.  Statistical  analysis  was  per-
formed  by  Mann-Whitney  U  test  and  using 
SPSS software version 15, with α level < 0.05 
as statistically significant.  
 
RESULTS 
A  total  of  45  patients  (17  female,  28  male) 
who had undergone H. pylori eradication re-
gimen were enrolled into the present study. Of 
these 45 patients, 15 had unsuccessful eradica-
tion. There were no significant differences be-
tween successful and unsuccessful eradication 
groups  regarding  sex  and  age  (p=0.82  and 
p=0.11, respectively) (Table 1). The median of 
salivary  secretion  rate  among  unsuccessful 
eradication  subjects  was  lower  than  the  suc-
cessful eradication group (p=0.005) (Table 2).  
 
DISCUSSION 
The microbiological, serological and DNA ge-
nomic results provide evidence that H. pylori 












On the other hand; it has been noted that H. 
pylori detection in the oral cavity is associated 
with gastroesophageal diseases [3]. Thus fail-
ure to eradicate H. pylori from the mouth may 
lead to reinfection of the stomach after treat-
ment [4,5,7,8]. In the oral cavity, H. pylori was 
detected in dental plaques, oral lesions and in 
the saliva [15]. It has been noted that poor pe-
riodontal health characterized by gingivitis and 
chronic  periodontitis  may  be  associated  with 
H. pylori infection and considered as a poten-
tial  reservoir  of  these  bacteria  [16,  17].  It  is 
therefore  suggested  that  professional  plaque 
removal  and  oral  hygiene  procedures  should 
be performed along with eradication strategies 
of H. pylori [9]. The role of saliva in maintain-
ing oral health is clear. There are possible im-
portant factors in the elimination of H. pylori 
from  the  oral  cavity  including  the  cleansing 
effect  of  saliva,  salivary  antibacterial  sub-
stances against H. pylori such as specific IgA, 
IgG, lactoferrin and EGF as well as salivary 
secretion  of  anti-H.  pylori  antibiotics 
[6,18,19].  
Namiot et al. [6] reported that low salivary se-
cretion may contribute to the decrease in effi-
cacy  of  H.  pylori  eradication  from  the  sto-
mach, especially in patients with certain drug 
regimens  including  omeprazole,  amoxicillin 
and tinidazole.  
They compared the effect of two different drug 
regimens  on  the  eradication  of  H.  pylori  re-
















Eradication                  Number            Salivary Secretion       Salivary Secretion         P vaue 
                                                     (median)                                     (mean rank) 
Successful                                    30                                       0.48                                           26.8 
                                                                                                                                                                                                  0.005
* 
Unsuccessful                              15                                       0.24                                           15.2                             
  *Mann-Whitney U test 
 
    Table 2. Salivary Secretion (ml/min) Regarding the Efficacy of H. Pylori Eradication 
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In the present study, we provided just one an-
tibiotic regimen for all patients and considered 
more  confounding  variables.  So  it  may  be 
noted since the salivary concentration of cer-
tain drugs is somewhat steady among all stu-
died patients, lower saliva flow rate may result 
in insufficient infiltration of drugs into the oral 
cavity  and  promote  unsuccessful  H.  pylori 
eradication from the mouth after treatment of 
the stomach. We also evaluated the efficacy of 
H.  pylori  eradication  from  the  stomach  at  4 
weeks after the end of antibiotic therapy be-
cause  this  is  a  proper  long  time  for  the  oral 
bacteria to survive from the eradication regi-
men and then reinfect the stomach [5,6]. Al-
though  few  studies  have  been  published  re-
garding the effect of salivary secretion on the 
efficacy  of  H.  pylori  regimens,  our  present 
study  which  is  in  agreement  with  Namiot  et 
al’s  reports  [6,20,21]  emphasized  that  saliva 
secretion may be one of the many causes of H. 
pylori eradication failure. However, we strong-
ly  recommend  further,  more  comprehensive 




There is increasing evidence that the mouth is 
a permanent reservoir of H. pylori, so eradica-
tion  regimens  should  simultaneously  destroy 
H.  pylori  in  both  the  stomach  and  the  oral 
cavity.  
For  this  reason,  it  may  be  necessary  to  pay 
close attention to the quantity and quality of 
saliva in order to reduce the recurrency of gas-
tric infections.       
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